Analysis of inhibitor binding in influenza virus neuraminidase

被引:90
|
作者
Smith, BJ
Colman, PM
Von Itzstein, M
Danylec, B
Varghese, JN
机构
[1] Biomol Res Inst, Parkville, Vic 3052, Australia
[2] Monash Univ, Dept Med Chem, Parkville, Vic 3052, Australia
关键词
influenza virus; neuraminidase inhibitors; electrostatics; X-ray crystal structures; binding energies; molecular modeling;
D O I
10.1110/ps.41801
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2,3-didehydro-2-deoxy-N-acetylneuraminic acid (DANA) is a transition state analog inhibitor of influenza virus neuraminidase (NA). Replacement of the hydroxyl at the C-9 position in DANA and 4-amino-DANA with an amine group, with the intention of taking advantage of an increased electrostatic interaction with a conserved acidic group in the active site to improve inhibitor binding, significantly reduces the inhibitor activity of both compounds. The three-dimensional X-ray structure of the complexes of these ligands and NA was obtained to 1.4 Angstrom resolution and showed that both ligands bind isosterically to DANA. Analysis of the geometry of the ammonium at the C-4 position indicates that Glu119 may be neutral when these ligands bind. A computational analysis of the binding energies indicates that the substitution is successful in increasing the energy of interaction; however, the gains that are made are not sufficient to overcome the energy that is required to desolvate that part of the ligand that comes in contact with the protein.
引用
下载
收藏
页码:689 / 696
页数:8
相关论文
共 50 条
  • [41] Influenza Virus Neuraminidase: Structure and Function
    Shtyrya, Y. A.
    Mochalova, L. V.
    Bovin, N. V.
    ACTA NATURAE, 2009, 1 (02): : 26 - 32
  • [42] INFLUENZA VIRUS NEURAMINIDASE AND VIRAL SURFACE
    KENDAL, AP
    BIDDLE, F
    BELYAVIN, G
    BIOCHIMICA ET BIOPHYSICA ACTA, 1968, 165 (03) : 419 - &
  • [43] Drugs targeting influenza virus neuraminidase
    Colman, PM
    STRUCTURE-BASED DRUG DESIGN: EXPERIMENTAL AND COMPUTATIONAL APPROACHES, 1998, 352 : 87 - 93
  • [44] Structure and functions of influenza virus neuraminidase
    Gong, Jianzhi
    Xu, Wenfang
    Zhang, Jie
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (01) : 113 - 122
  • [45] SEQUENCING INFLUENZA-VIRUS NEURAMINIDASE
    BLOK, J
    PROCEEDINGS OF THE AUSTRALIAN BIOCHEMICAL SOCIETY, 1979, 12 : 71 - 71
  • [46] Influenza virus resistance to neuraminidase inhibitors
    Mendel, DB
    Sidwell, RW
    DRUG RESISTANCE UPDATES, 1998, 1 (03) : 184 - 189
  • [47] Inhibitors of influenza virus neuraminidase and endonuclease
    Sham, HL
    Chen, XQ
    CURRENT PHARMACEUTICAL DESIGN, 1997, 3 (02) : 159 - 168
  • [48] Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140
    Bantia, S
    Ghate, AA
    Ananth, SL
    Babu, YS
    Air, GM
    Walsh, GM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 801 - 807
  • [49] Substrate, inhibitor, or antibody stabilizes the Glu 119 Gly mutant influenza virus neuraminidase
    Sahasrabudhe, A
    Lawrence, L
    Epa, VC
    Varghese, JN
    Colman, PM
    McKimm-Breschkin, JL
    VIROLOGY, 1998, 247 (01) : 14 - 21
  • [50] Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor RWJ-270201
    Bantia, S
    Ananth, S
    Horn, L
    Parker, C
    Gulati, U
    Chand, P
    Babu, Y
    Air, G
    ANTIVIRAL RESEARCH, 2000, 46 (01) : A60 - A60